Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-01-05 @ 10:00 PM
Study NCT ID:
NCT00679133
Status:
COMPLETED
Last Update Posted:
2015-01-08
First Post:
2008-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies
Sponsor:
Mirati Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-14
First Submit QC Date:
None
Study First Post Date:
2008-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-06
Last Update Post Date:
2015-01-08
Last Update Post Date Type:
ESTIMATED